Stock Research for TARO

TARO

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

TARO Stock Chart & Research Data

The TARO chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the TARO chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


TARO Due diligence Resources & Stock Charts

The TARO stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View TARO Detailed Price Forecast - CNN Money CNN View TARO Detailed Summary - Google Finance
Yahoo View TARO Detailed Summary - Yahoo! Finance Zacks View TARO Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View TARO Trends & Analysis - Trade-Ideas Barrons View TARO Major Holders - Barrons
NASDAQ View TARO Call Transcripts - NASDAQ Seeking View TARO Breaking News & Analysis - Seeking Alpha
Spotlight View TARO Annual Report - CompanySpotlight.com OTC Report View TARO OTC Short Report - OTCShortReport.com
TradeKing View TARO Fundamentals - TradeKing Charts View TARO SEC Filings - Bar Chart
WSJ View Historical Prices for TARO - The WSJ Morningstar View Performance/Total Return for TARO - Morningstar
MarketWatch View the Analyst Estimates for TARO - MarketWatch CNBC View the Earnings History for TARO - CNBC
StockMarketWatch View the TARO Earnings - StockMarketWatch MacroAxis View TARO Buy or Sell Recommendations - MacroAxis
Bullish View the TARO Bullish Patterns - American Bulls Short Pains View TARO Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View TARO Stock Mentions - StockTwits PennyStocks View TARO Stock Mentions - PennyStockTweets
Twitter View TARO Stock Mentions - Twitter Invest Hub View TARO Investment Forum News - Investor Hub
Yahoo View TARO Stock Mentions - Yahoo! Message Board Seeking Alpha View TARO Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for TARO - SECform4.com Insider Cow View Insider Transactions for TARO - Insider Cow
CNBC View TARO Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for TARO - OTC Markets
Yahoo View Insider Transactions for TARO - Yahoo! Finance NASDAQ View Institutional Holdings for TARO - NASDAQ


Stock Charts

FinViz View TARO Stock Insight & Charts - FinViz.com StockCharts View TARO Investment Charts - StockCharts.com
BarChart View TARO Stock Overview & Charts - BarChart Trading View View TARO User Generated Charts - Trading View




Latest Financial News for TARO


Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.
Posted on Monday April 15, 2024

NEW YORK, April 15, 2024--Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.


Krensavage Asset Management Remains Opposed to Sun's Predatory Bid for Taro
Posted on Tuesday January 30, 2024

Krensavage Asset Management today sent the following message to a special committee evaluating Sun Pharmaceutical Industries Ltd.'s bid for Taro Pharmaceutical Industries Ltd.


Taro Provides Results for December 31, 2023
Posted on Thursday January 25, 2024

HAWTHORNE, N.Y., January 25, 2024--TARO PROVIDES RESULTS FOR DECEMBER 31, 2023


India's Sun Pharma to buy remaining stake in Israeli unit Taro for about $348 million
Posted on Wednesday January 17, 2024

The Indian drugmaker, which currently owns about 78.5% stake in Taro, had offered to buy its remaining stake for $38 per share in May. Upon completion of the merger, which is expected to close in the first half of the year, Taro would become a privately held company and will be delisted from the New York Stock Exchange, the companies said. The U.S. government had in November dismissed charges against a former Taro executive who was accused of conspiring to fix generic drug prices between 2013 and 2015.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.